158 related articles for article (PubMed ID: 26806863)
1. Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
Altmann V; Schumacher-Schuh AF; Rieck M; Callegari-Jacques SM; Rieder CR; Hutz MH
Neurosci Lett; 2016 Feb; 615():88-91. PubMed ID: 26806863
[TBL] [Abstract][Full Text] [Related]
2. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
[TBL] [Abstract][Full Text] [Related]
3. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
[TBL] [Abstract][Full Text] [Related]
4. BDNF Val66Met polymorphism and cognitive impairment in Parkinson's disease-a meta-analysis.
Yin Y; Su X; Pan L; Li C
Neurol Sci; 2019 Sep; 40(9):1901-1907. PubMed ID: 31104169
[TBL] [Abstract][Full Text] [Related]
5. BDNF polymorphism associates with decline in set shifting in Parkinson's disease.
van der Kolk NM; Speelman AD; van Nimwegen M; Kessels RP; IntHout J; Hakobjan M; Munneke M; Bloem BR; van de Warrenburg BP
Neurobiol Aging; 2015 Mar; 36(3):1605.e1-6. PubMed ID: 25444596
[TBL] [Abstract][Full Text] [Related]
6. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
[TBL] [Abstract][Full Text] [Related]
7. Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms.
Cagni FC; Campêlo CLDC; Coimbra DG; Barbosa MR; Júnior LGO; Neto ABS; Ribeiro AM; Júnior COG; Gomes de Andrade T; Silva RH
J Neuropsychiatry Clin Neurosci; 2017; 29(2):142-147. PubMed ID: 27852165
[TBL] [Abstract][Full Text] [Related]
8. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
[TBL] [Abstract][Full Text] [Related]
11. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.
Foltynie T; Lewis SG; Goldberg TE; Blackwell AD; Kolachana BS; Weinberger DR; Robbins TW; Barker RA
J Neurol; 2005 Jul; 252(7):833-8. PubMed ID: 15772739
[TBL] [Abstract][Full Text] [Related]
12. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
14. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
[TBL] [Abstract][Full Text] [Related]
16. Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis.
Wang Q; Liu J; Guo Y; Dong G; Zou W; Chen Z
Braz J Med Biol Res; 2019; 52(8):e8443. PubMed ID: 31365694
[TBL] [Abstract][Full Text] [Related]
17. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.
Gao L; Díaz-Corrales FJ; Carrillo F; Díaz-Martín J; Caceres-Redondo MT; Carballo M; Palomino A; López-Barneo J; Mir P
Acta Neurol Scand; 2010 Jul; 122(1):41-5. PubMed ID: 20085561
[TBL] [Abstract][Full Text] [Related]
19. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population.
Nie K; Zhang Y; Gan R; Wang L; Zhao J; Huang Z; Tang H; Wang L
Neurosci Lett; 2013 Apr; 541():111-5. PubMed ID: 23485736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
